CURE.DE vs. WH2E.DE
CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) and WH2E.DE (Invesco S&P World Health Care ESG UCITS ETF Acc) are both Health & Biotech Equities funds - CURE.DE tracks the MVIS Global Future Healthcare ESG while WH2E.DE tracks the S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care. Both are passively managed. Over the past 3 years, CURE.DE returned -2.48%/yr vs 3.13%/yr for WH2E.DE. At a 0.48 correlation, their price movements are largely independent. CURE.DE charges 0.35%/yr vs 0.18%/yr for WH2E.DE.
Performance
CURE.DE vs. WH2E.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE.DE achieves a -5.10% return, which is significantly lower than WH2E.DE's -3.24% return.
CURE.DE
- 1D
- 4.01%
- 1M
- 6.73%
- YTD
- -5.10%
- 6M
- -8.62%
- 1Y
- 6.04%
- 3Y*
- -2.48%
- 5Y*
- —
- 10Y*
- —
WH2E.DE
- 1D
- 2.76%
- 1M
- 4.00%
- YTD
- -3.24%
- 6M
- -2.44%
- 1Y
- 10.44%
- 3Y*
- 3.13%
- 5Y*
- —
- 10Y*
- —
CURE.DE vs. WH2E.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | -5.10% | 5.09% | 0.30% | -7.72% |
WH2E.DE Invesco S&P World Health Care ESG UCITS ETF Acc | -3.24% | 2.78% | 7.94% | 1.68% |
Correlation
The correlation between CURE.DE and WH2E.DE is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.56 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.48 |
Correlation (All Time) Calculated using the full available price history since Apr 18, 2023 | 0.48 |
The correlation between CURE.DE and WH2E.DE has been stable across timeframes, ranging from 0.48 to 0.56 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE.DE vs. WH2E.DE — Risk / Return Rank
CURE.DE
WH2E.DE
CURE.DE vs. WH2E.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) and Invesco S&P World Health Care ESG UCITS ETF Acc (WH2E.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CURE.DE | WH2E.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.39 | ||
| Sortino ratioReturn per unit of downside risk | -0.58 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.13 | -0.06 |
| Calmar ratioReturn relative to maximum drawdown | 0.30 | 0.83 | -0.53 |
| Martin ratioReturn relative to average drawdown | 0.68 | 2.15 | -1.47 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CURE.DE | WH2E.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.29 | 0.68 | -0.39 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.14 | 0.20 | -0.34 |
Drawdowns
CURE.DE vs. WH2E.DE - Drawdown Comparison
The maximum CURE.DE drawdown since its inception was -34.80%, which is greater than WH2E.DE's maximum drawdown of -22.19%. Use the drawdown chart below to compare losses from any high point for CURE.DE and WH2E.DE.
Loading charts...
Drawdown Indicators
| CURE.DE | WH2E.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.80% | -22.19% | -12.61% |
Max Drawdown (1Y)Largest decline over 1 year | -19.07% | -12.23% | -6.84% |
Max Drawdown (3Y)Largest decline over 3 years | -29.32% | -22.19% | -7.13% |
Current DrawdownCurrent decline from peak | -15.66% | -10.45% | -5.21% |
Average DrawdownAverage peak-to-trough decline | -15.12% | -6.94% | -8.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.53% | 4.73% | +3.80% |
Volatility
CURE.DE vs. WH2E.DE - Volatility Comparison
VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) has a higher volatility of 5.73% compared to Invesco S&P World Health Care ESG UCITS ETF Acc (WH2E.DE) at 5.21%. This indicates that CURE.DE's price experiences larger fluctuations and is considered to be riskier than WH2E.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE.DE | WH2E.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.73% | 5.21% | +0.52% |
Volatility (6M)Calculated over the trailing 6-month period | 15.20% | 10.46% | +4.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.97% | 14.86% | +5.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.74% | 13.91% | +6.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.74% | 13.91% | +6.83% |
CURE.DE vs. WH2E.DE - Expense Ratio Comparison
CURE.DE has a 0.35% expense ratio, which is higher than WH2E.DE's 0.18% expense ratio.
Dividends
CURE.DE vs. WH2E.DE - Dividend Comparison
Neither CURE.DE nor WH2E.DE has paid dividends to shareholders.
Frequently Asked Questions
CURE.DE and WH2E.DE have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, WH2E.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
WH2E.DE is cheaper with a 0.18% expense ratio, compared with 0.35% for CURE.DE.
CURE.DE tracks MVIS Global Future Healthcare ESG, while WH2E.DE tracks S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care. They also come from different issuers: VanEck and Invesco. Their fees differ too: 0.35% for CURE.DE and 0.18% for WH2E.DE.
Find the right allocation for CURE.DE and WH2E.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer